Erlanger Joins Clinical Trial Aiming To Reduce Stroke In Atrial Fibrillation Patients chattanoogan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chattanoogan.com Daily Mail and Mail on Sunday newspapers.
FEMALE NEWSREADER:
LAURA SULLIVAN:
MALE NEWSREADER:
It’s a huge problem not just in the Latino community, but also in the Black community.
LAURA SULLIVAN:
This is a story about those hospitals, largely government-funded, whose primary mission is to care for the poor and uninsured. They’re called safety-net hospitals.
BRAD SPELLBERG, M.D., Chief Med. Director, LAC+USC:
Why are safety nets hit the hardest? Because our patients are vulnerable. We serve a community of working poor. We serve people who are working essential jobs.
Buenos días, señor.
Homeless patients. Patients with mental illness. Substance abuse addiction disorder. We are expected to care for the patients the other hospitals won’t care for.
Patchy Growth of TAVR Programs Leaves Poorer Communities Behind medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Erlanger Hires Structural Interventional Cardiologist Dr. Megan Coylewright Thursday, February 18, 2021 The Erlanger Heart and Lung Institute has added Megan Coylewright, MD, MPH, FSCAI, FACC, to its team of cardiology providers as director of the Structural Heart Program. In this role, Dr. Coylewright will lead a team that treats valvular and structural heart disease while expanding access to state-of-the-art cardiovascular device clinical trials in the region. Dr. Coylewright is board-certified in the areas of cardiology and interventional cardiology. As a structural interventionalist, she performs minimally invasive valve repair and replacement, offering alternatives to traditional surgery. Her expertise includes transcatheter aortic valve replacement (TAVR), including expanded options for patients with diseased blood vessels or failed surgical valves.
Erlanger Appoints Cheryl Wieber As Senior Director Of Cardiovascular Services Wednesday, January 6, 2021 In her role, Ms. Wieber will lead the overall operations, quality improvement, program development and clinical education efforts of the Erlanger Heart and Lung Institute. “Cheryl is a very accomplished healthcare administrator whom we are lucky to have join our team at Erlanger Heart and Lung Institute,” said Senior Vice President of Erlanger Medical Group Meridith O’Keefe. “She brings to Erlanger a wealth of knowledge about management of cardiovascular services in critical care access hospitals.” Ms. Wieber has over 13 years of administrative leadership experience in healthcare and has overseen clinical areas such as cardiology, vascular surgery and cardiothoracic surgery.